Janus Living Inc (JAN)

NYSEReal EstateReit - DiversifiedSnapshot 2026-10-15

$29.05-0.82%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Janus Living Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Successful public offering of 25 million Class A-1 shares	It raised capital by selling 25 million shares.	Intact	Failure to maintain capital from the 25 million share offering	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Diluted EPS between $0.23 and $0.27	The company guides 2026 EPS between $0.23 and $0.27.	Intact	Diluted EPS falls below $0.23 in FY26	Diluted EPS: $0.05 per share FY2026-Q2; GAAP. Published target: EPS between $0.23 and $0.27. Target period is not explicitly aligned with this observation. Source published Aug 5, 20260.05 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5743cdbf-528e-4670-b5e8-c88c8a3bbf37. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Management raised full year 2026 diluted EPS guidance from $0.23 - $0.27 to $0.34 - $0.37. Actual diluted EPS was -$0.05 in 2026-Q1 and improved to $0.05 in 2026-Q2. The trajectory shows improvement aligned with updated guidance. Delivery assessment Oct 15, 2026
Same-Store Adjusted NOI growth of 11% - 15%	Janus Living aims for 11% to 15% growth in same-store NOI.	Intact	Same-Store Adjusted NOI growth falls below 11% in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Same-store adjusted NOI grew 13.8% in 2026-Q1 and 19.2% in 2026-Q2, exceeding prior guidance of 11% - 15%. Management raised full-year 2026 guidance to 13% - 17%. The trajectory is delivering with growth above initial targets. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue$1.23B

$1.07B → $1.23B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$1,071,053,530	3 / 9
2026-07-25	Unavailable	$1,086,351,709	3 / 7
2026-07-26	Unavailable	$1,071,053,530	3 / 9
2026-07-27	Unavailable	$1,086,392,889	3 / 7
2026-07-28	Unavailable	$1,086,392,889	3 / 7
2026-07-29	Unavailable	$1,071,053,530	3 / 9
2026-07-30	Unavailable	$1,071,053,530	3 / 9
2026-07-31	Unavailable	$1,086,392,889	3 / 7
2026-08-01	Unavailable	$1,086,392,889	3 / 7
2026-08-02	Unavailable	$1,071,053,530	3 / 9
2026-08-03	Unavailable	$1,071,053,530	3 / 9
2026-08-04	Unavailable	$1,071,053,530	3 / 9
2026-08-05	Unavailable	$1,071,053,530	3 / 9
2026-08-06	Unavailable	$1,086,392,889	3 / 7
2026-08-07	Unavailable	$1,123,703,389	3 / 7
2026-08-08	Unavailable	$1,112,497,980	3 / 9
2026-08-09	Unavailable	$1,112,497,980	3 / 9
2026-08-10	Unavailable	$1,112,497,980	3 / 9
2026-08-12	Unavailable	$1,123,703,389	3 / 7
2026-08-13	Unavailable	$1,123,703,389	3 / 7
2026-08-14	Unavailable	$1,123,703,389	3 / 7
2026-08-15	Unavailable	$1,123,703,389	3 / 7
2026-08-16	Unavailable	$1,123,703,389	3 / 7
2026-08-17	Unavailable	$1,123,703,389	3 / 7
2026-08-18	Unavailable	$1,123,703,389	3 / 7
2026-08-19	Unavailable	$1,123,703,389	2 / 7
2026-08-20	Unavailable	$1,188,786,489	2 / 8
2026-08-21	Unavailable	$1,188,786,489	3 / 8
2026-08-22	Unavailable	$1,188,786,489	3 / 8
2026-08-23	Unavailable	$1,187,090,140	3 / 8
2026-08-24	Unavailable	$1,187,090,140	3 / 8
2026-08-25	Unavailable	$1,187,090,140	3 / 8
2026-08-26	Unavailable	$1,187,090,140	3 / 8
2026-08-27	Unavailable	$1,187,090,140	3 / 8
2026-08-28	Unavailable	$1,187,090,140	3 / 8
2026-08-29	Unavailable	$1,187,090,140	3 / 8
2026-08-30	Unavailable	$1,187,090,140	3 / 8
2026-08-31	Unavailable	$1,187,090,140	3 / 8
2026-09-01	Unavailable	$1,187,090,140	3 / 8
2026-09-02	Unavailable	$1,191,240,997	3 / 8
2026-09-03	Unavailable	$1,192,537,197	3 / 8
2026-09-04	Unavailable	$1,199,043,067	3 / 8
2026-09-05	Unavailable	$1,199,043,067	3 / 8
2026-09-06	Unavailable	$1,199,043,067	3 / 8
2026-09-07	Unavailable	$1,199,043,067	3 / 8
2026-09-08	Unavailable	$1,199,043,067	3 / 8
2026-09-09	Unavailable	$1,199,043,067	3 / 8
2026-09-10	Unavailable	$1,199,043,067	3 / 8
2026-09-11	Unavailable	$1,199,043,067	3 / 8
2026-09-12	Unavailable	$1,199,043,067	3 / 8
2026-09-13	Unavailable	$1,199,043,067	3 / 8
2026-09-14	Unavailable	$1,199,043,067	3 / 8
2026-09-15	Unavailable	$1,199,043,067	3 / 8
2026-09-16	Unavailable	$1,225,575,516	3 / 8
2026-09-17	Unavailable	$1,225,575,516	3 / 8
2026-09-18	Unavailable	$1,225,575,516	3 / 8
2026-09-19	Unavailable	$1,225,532,743	3 / 8
2026-09-20	Unavailable	$1,225,532,743	3 / 8
2026-09-21	Unavailable	$1,225,532,743	3 / 8
2026-09-22	Unavailable	$1,225,532,743	3 / 8
2026-09-23	Unavailable	$1,225,532,743	3 / 8
2026-09-24	Unavailable	$1,225,532,743	3 / 8
2026-09-25	Unavailable	$1,225,532,743	3 / 8
2026-09-26	Unavailable	$1,225,532,743	3 / 8
2026-09-27	Unavailable	$1,225,532,743	3 / 8
2026-09-28	Unavailable	$1,225,532,743	3 / 8
2026-09-29	Unavailable	$1,225,532,743	3 / 8
2026-09-30	Unavailable	$1,225,532,743	3 / 8
2026-10-01	Unavailable	$1,225,532,743	3 / 8
2026-10-02	Unavailable	$1,225,532,743	3 / 8
2026-10-03	Unavailable	$1,225,532,743	3 / 8
2026-10-04	Unavailable	$1,225,461,270	3 / 8
2026-10-05	Unavailable	$1,225,461,270	3 / 8
2026-10-06	Unavailable	$1,225,441,834	3 / 8
2026-10-07	Unavailable	$1,225,441,834	3 / 8
2026-10-08	Unavailable	$1,225,441,834	3 / 8
2026-10-09	Unavailable	$1,225,441,834	3 / 8
2026-10-10	Unavailable	$1,225,441,834	3 / 8
2026-10-11	Unavailable	$1,225,441,834	3 / 8
2026-10-12	Unavailable	$1,225,441,834	3 / 8
2026-10-13	Unavailable	$1,225,441,834	3 / 8
2026-10-14	Unavailable	$1,225,441,834	3 / 8
2026-10-15	Unavailable	$1,225,441,834	3 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	10	1
2026-06-01	11	1
2026-07-01	11	1
2026-08-01	11	1
2026-09-01	12	2
2026-10-01	12	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 12 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 16–Oct 15 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

ScotiabankSep 17 · prior Sep 2

$31.00 → $33.00+6.5%

Compass PointSep 16

$37.00New observation · no comparable prior

$0$20.35$40.70

1 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Successful public offering of 25 million Class A-1 sharesDirect metric needs a verified mapping
Diluted EPS between $0.23 and $0.27Diluted EPS: $0.05 per share
Same-Store Adjusted NOI growth of 11% - 15%Direct metric needs a verified mapping

Next proof point

Nov 2, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-12.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Janus Living Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a long-term thesis on a company in the real estate sector. It is characterized by a mix of growth and value elements, with management focusing on acquisitions and same-store growth despite being currently loss-making.

What's priced into Janus Living Inc

The market appears to price in a durable premium compared to peers, suggesting that investors expect some level of performance improvement. However, there is a divergence in expectations, indicating that the current valuation may reflect optimism about future growth.

What the fundamentals likely do

Management has shown progress in same-store adjusted NOI growth and improving diluted EPS guidance. However, the overall trajectory is mixed, with some priorities on track and others showing uncertainty.

What Janus Living Inc hinges on

The thesis hinges on whether JAN can maintain its growth trajectory and avoid cutting guidance, which would damage credibility. Additionally, external factors like Federal Reserve rate cuts and the performance of sector peers will play a crucial role in shaping future outcomes.